![](https://cdn.sanity.io/images/0vv8moc6/mhe/40a10bd9656e32abd90730c0b5e65d119efed282-5126x2926.jpg?fit=crop&auto=format)
In This Syfovre-Izervay Comparison, Syfovre Gets the Nod | ASRS 2024
The FDA approved treatments for geographic atrophy for the first time last year,first Apellis Pharmaceuticals’ Syfovre (pegcetacoplan) in February and then Astella Pharma’s Izervay (avacincaptad pegol) in August. The approvals have presented retinal …